ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.606,58
0,67%
S&P 500
5.272,03
-0,10%
Dow Jones
38.431,45
-0,66%
Euro vs US Dollar
1,08855
0,27%
Bitcoin
69.279,85
2,26%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Genelux Corporation (GNLX)

  7. Genelux Corporation (GNLX) News

GNLX

Genelux (GNLX)

Genelux Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:GNLX
DatumZeitQuelleÜberschriftSymbolFirma
24/05/202423h19Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GNLXGenelux Corporation
24/05/202414h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GNLXGenelux Corporation
24/05/202414h00GlobeNewswire Inc.Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying WarrantsNASDAQ:GNLXGenelux Corporation
23/05/202422h59Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GNLXGenelux Corporation
23/05/202422h01GlobeNewswire Inc.Genelux Corporation Announces Proposed Public Offering of Common Stock and WarrantsNASDAQ:GNLXGenelux Corporation
15/05/202423h59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
09/05/202422h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
09/05/202422h25GlobeNewswire Inc.Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business UpdatesNASDAQ:GNLXGenelux Corporation
09/05/202422h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GNLXGenelux Corporation
01/04/202413h00GlobeNewswire Inc.Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:GNLXGenelux Corporation
14/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GNLXGenelux Corporation
05/02/202415h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GNLXGenelux Corporation
02/02/202422h39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GNLXGenelux Corporation
02/02/202422h36Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GNLXGenelux Corporation
02/02/202422h06Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GNLXGenelux Corporation
18/12/202322h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
15/12/202322h08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GNLXGenelux Corporation
15/12/202302h59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
15/12/202302h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
13/12/202322h59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GNLXGenelux Corporation
13/12/202322h35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GNLXGenelux Corporation
12/12/202314h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GNLXGenelux Corporation
08/12/202323h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
07/12/202323h02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GNLXGenelux Corporation
27/11/202313h00GlobeNewswire Inc.Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian CancerNASDAQ:GNLXGenelux Corporation
24/11/202319h14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GNLXGenelux Corporation
22/11/202322h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GNLXGenelux Corporation
17/11/202323h40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GNLXGenelux Corporation
14/11/202323h50GlobeNewswire Inc.Genelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business UpdatesNASDAQ:GNLXGenelux Corporation
14/11/202322h24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GNLXGenelux Corporation
 Showing the most relevant articles for your search:NASDAQ:GNLX

Kürzlich von Ihnen besucht

BIT
P1R395
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten